EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Continuous, but not intermittent, regimens of hypoxia prevent and reverse ataxia in a murine model of Friedreich’s ataxia

Tslil Ast iD, Hong Wang, Eizo Marutani, Fumiaki Nagashima, Rajeev Malhotra, Fumito Ichinose, Vamsi K Mootha

Human Molecular Genetics · 2023

DOI: 10.1093/hmg/ddad091 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Molecular Genetics, 2023. Verfasst von Tslil Ast und 6 weiteren Autor:innen. Beteiligte Einrichtung: Broad Institute, Cambridge, MA 02142, USA. Hauptthemen laut MEDLINE: Friedreich Ataxia, Neurodegenerative Diseases, Polycythemia. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NINDS NIH HHS, Friedreich's Ataxia Research Alliance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Friedreich’s ataxia (FA) is a devastating, multi-systemic neurodegenerative disease affecting thousands of people worldwide. We previously reported that oxygen is a key environmental variable that can modify FA pathogenesis. In particular, we showed that chronic, continuous normobaric hypoxia (11% FIO2) prevents ataxia and neurological disease in a murine model of FA, although it did not improve cardiovascular pathology or lifespan. Here, we report the pre-clinical evaluation of seven ‘hypoxia-inspired’ regimens in the shFxn mouse model of FA, with the long-term goal of designing a safe, practical and effective regimen for clinical translation. We report three chief results. First, a daily, intermittent hypoxia regimen (16 h 11% O2/8 h 21% O2) conferred no benefit and was in fact harmful, resulting in elevated cardiac stress and accelerated mortality. The detrimental effect of this regimen is likely owing to transient tissue hyperoxia that results when daily exposure to 21% O2 combines with chronic polycythemia, as we could blunt this toxicity by pharmacologically inhibiting polycythemia. Second, we report that more mild regimens of chronic hypoxia (17% O2) confer a modest benefit by delaying the onset of ataxia. Third, excitingly, we show that initiating chronic, continuous 11% O2 breathing once advanced neurological disease has already started can rapidly reverse ataxia. Our studies showcase both the promise and limitations of candidate hypoxia-inspired regimens for FA and underscore the need for additional pre-clinical optimization before future translation into humans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Friedreich AtaxiaNeurodegenerative DiseasesPolycythemiaHumansMiceAnimalsDisease Models, AnimalHypoxiaOxygenAtaxia

Substanzen

Oxygen

Autor:innen und Institutionen

  • Broad Institute, Cambridge, MA 02142, USA.
  • Howard Hughes Medical Institute, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA.
  • Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.

ORCID-Profile: Tslil Ast

Förderung

  • NHLBI NIH HHS
  • NINDS NIH HHS
  • Friedreich's Ataxia Research Alliance
  • Marriott Family Foundation
  • National Institutes of Health
  • Howard Hughes Medical Institute

Zitieren

APA

Ast, T., Wang, H., Marutani, E., Nagashima, F., Malhotra, R., Ichinose, F., & Mootha, V. K. (2023). Continuous, but not intermittent, regimens of hypoxia prevent and reverse ataxia in a murine model of Friedreich’s ataxia. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddad091

Vancouver

Ast T, Wang H, Marutani E, Nagashima F, Malhotra R, Ichinose F, et al. Continuous, but not intermittent, regimens of hypoxia prevent and reverse ataxia in a murine model of Friedreich’s ataxia. Human Molecular Genetics. 2023. doi:10.1093/hmg/ddad091

BibTeX
@article{Ast2023,
  author = {Ast, Tslil and Wang, Hong and Marutani, Eizo and Nagashima, Fumiaki and Malhotra, Rajeev and Ichinose, Fumito and Mootha, Vamsi K},
  title = {Continuous, but not intermittent, regimens of hypoxia prevent and reverse ataxia in a murine model of Friedreich’s ataxia},
  journal = {Human Molecular Genetics},
  year = {2023},
  doi = {10.1093/hmg/ddad091}
}
Kostenlos starten →